Brain Advance Access originally published online on September 29, 2006
Brain 2006 129(11):2908-2922; doi:10.1093/brain/awl266
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years
1 Division of Psychiatry Research University of Zurich 2 Institute for Biomedical Engineering University and ETH Zurich, Zurich 3 Department of Psychology University of Bern, Bern, Switzerland
Correspondence to: Katharina Henke, Department of Psychology, University of Bern, Muesmattstrasse 45, 3000 Bern 9, Switzerland E-mail: henke{at}psy.unibe.ch
Presenilin 1 (PSEN1) mutations cause autosomal dominant familial Alzheimer's disease (FAD). PSEN1 mutation carriers undergo the course of cognitive deterioration, which is typical for sporadic Alzheimer's disease but disease onset is earlier and disease progression is faster. Here, we sought to detect signs of FAD in presymptomatic carriers of the PSEN1 mutation (C410Y) by use of a neuropsychological examination, functional MRI during learning and memory tasks and MRI volumetry. We examined five non-demented members of a FAD family and 21 non-related controls. Two of the five family members were carrying the mutation; one was 20 years old and the other 45 years old. The age of clinical manifestation of FAD in the family studied here is
48 years. Neuropsychological assessments suggested subtle problems with episodic memory in the 20-year-old mutation carrier. The middle-aged mutation carrier fulfilled criteria for amnestic mild cognitive impairment. The 20-year-old mutation carrier exhibited increased, while the middle-aged mutation carrier exhibited decreased brain activity compared to controls within memory-related neural networks during episodic learning and retrieval, but not during a working-memory task. The increased memory-related brain activity in the young mutation carrier might reflect a compensatory effort to overcome preclinical neural dysfunction caused by first pathological changes. The activity reductions in the middle-aged mutation carrier might reflect gross neural dysfunction in a more advanced stage of neuropathology. These data suggest that functional neuroimaging along with tasks that challenge specifically those brain areas which are initial targets of Alzheimer's disease pathology may reveal activity alterations on a single-subject level decades before the clinical manifestation of Alzheimer's disease.
Key Words: presenilin 1; fMRI; hippocampus; learning; preclinical
Abbreviations:
APOE4, apolipoprotein E
4; CERAD-NAB, Consortium to Establish a Registry for Alzheimer's DiseaseNeuropsychological Assessment Battery; FAD, familial Alzheimer's disease; fMRI, functional MRI; HAWIE-R, Hamburg Wechsler Intelligence Scale Revised; MTL, medial temporal lobe; PSEN1, presenilin 1; ROI, region of interest; SAD, sporadic Alzheimer's disease; WMS-R, Wechsler Memory ScaleRevised
Received May 25, 2006. Revised August 25, 2006. Accepted August 29, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. A. Yassa, G. Verduzco, C. Cristinzio, and S. S. Bassett Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease Neurology, May 13, 2008; 70(20): 1898 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Miller, K. Celone, K. DePeau, E. Diamond, B. C. Dickerson, D. Rentz, M. Pihlajamaki, and R. A. Sperling Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation PNAS, February 12, 2008; 105(6): 2181 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Johnson, M. L. Ries, T. M. Hess, C. M. Carlsson, C. E. Gleason, A. L. Alexander, H. A. Rowley, S. Asthana, and M. A. Sager Effect of Alzheimer Disease Risk on Brain Function During Self-appraisal in Healthy Middle-aged Adults Arch Gen Psychiatry, October 1, 2007; 64(10): 1163 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
Differing Brain Activation in Familial AD: A Functional-MRI Study Journal Watch Neurology, February 6, 2007; 2007(206): 5 - 5. [Full Text] |
||||



